Long COVID More Common Among Socially Vulnerable Individuals
Access to Treatment Is a Severe Barrier for Patients With Mental Illness: Michael McGuire, PharmD
Lack of Diversity in Pulmonary Fibrosis Genetic Studies Limits Clinical Applicability: Ayodeji Adegunsoye, MD, PhD, MSc
Rural Health Investment, Local Training Are Priorities for South Jersey: State Sen Vincent Polistina
Addressing SDOH in Pediatric Dermatology to Improve Outcomes
Addressing Cardiovascular Risk and Intervening Early—Recording
AI Is Not Going to Replace Doctors, It’s Going to Empower Them: Dr Mehmet Oz
A Rising Researcher’s Take on Underrecognized Pediatric Skin Conditions: Hira Ghani, DO
Navigating Insurance Hurdles and Policy Shortfalls in Breast Cancer Care: Anasuya Gunturi, MD, PhD
Breaking Down Barriers to Hepatitis Elimination on World Hepatitis Day 2025
Health Equity in Hidradenitis Suppurativa: Addressing Care Disparities
Evaluating the Future of MS Therapies: Balancing Early Data With Delayed Outcomes
Closing Perspectives
Access to Treatment Is a Severe Barrier for Patients With Mental Illness: Michael McGuire, PharmD
Lack of Diversity in Pulmonary Fibrosis Genetic Studies Limits Clinical Applicability: Ayodeji Adegunsoye, MD, PhD, MSc
Debates, Deep Dives, and Prevention Strategies: What to Expect at ASPC 2025 With David J. Maron, MD, FASPC
Teledermatology and AI's Impact on Patient Access and Diagnostics: Hadar Avihai Lev-Tov, MD
Rural Health Investment, Local Training Are Priorities for South Jersey: State Sen Vincent Polistina
Chronic Skin Conditions in the Classroom and Online: Karen Vo, DO, Urges Unified Support and Awareness
AI, GLP-1s Among Topics to Be Discussed During ASPC Annual Meeting
Debates, Deep Dives, and Prevention Strategies: What to Expect at ASPC 2025 With David J. Maron, MD, FASPC
Chronic Skin Conditions in the Classroom and Online: Karen Vo, DO, Urges Unified Support and Awareness
Building a Better Future Through Technology, Advocacy, and Community
At ASCO, Testing and AI Rival Drugs for Attention, but Reimbursement Remains a Barrier
COCOON Shows How Prophylactic AE Management Boosts QOL When Treating NSCLC With Amivantamab Plus Lazertinib
Potential Health Literacy Resources for Health Plans: A Narrative Review
Population Health Reimagined Through Integrated Care
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
Optimizing Advanced Cancer Therapies and Addressing Logistical, Financial Challenges
Value-Based Care Calls for Putting Novel Therapies Closer to Patients
Will Subcutaneous PD-1/PD-L1 Inhibitors Be a Game Changer?
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)
From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape
Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professionals
Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape